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185Imaging of Low-Gradient Severe Aortic Stenosis
Although most patients with severe aortic stenosis (AS) have high peak velocity and mean transvalvular
gradient, there is a subset of patients with low-flow, low-gradient severe AS (LGSAS). Assessment and
managementof suchpatients canbedifficult anddobutamineechocardiographyhasbeen recommended
to distinguish those with pseudo-AS (low calculated AVA due to insufficient flow to fully open the valve)
from those with contractile reserve and true LGSAS, who may have good outcomes with surgery. More
recently, a group of patients with LGSAS and preserved LV function have been identified. These patients
are often elderly with hypertension, small left ventricular cavities, and concentric left ventricular hypertro-
phy. Because cardiac imaging plays a vital role in hemodynamic classification of patients with suspected
LGSAS and determining appropriate management, this review was undertaken to summarize the current
state of knowledge of this important but complex condition. (J Am Coll Cardiol Img 2013;6:184–95)
© 2013 by the American College of Cardiology Foundationortic stenosis (AS) is one of the most common
valvular disorders encountered in clinical
practice, and its prevalence is expected to
increase in the United States as the “baby
boomer” generation ages (1,2). It is the most
common indication for aortic valve replacement
(AVR), which is recommended for symptomatic
severe AS (3,4). Severe AS has been defined as a
calculated aortic valve area (AVA) 1.0 cm2, mean
ressure gradient (MPG) 40 mm Hg and peak
elocity 4 m/s (3,4). It is often recommended to
ndex the AVA for body surface area (0.6 cm2/m2),
which corresponds better with left ventricular
stroke work loss than AVA.
Most patients with severe AS maintain normal
left ventricular ejection fraction (LVEF) despite
significant afterload mismatch. In such patients, the
presence of an elevated MPG and/or peak velocity,
along with a decreased calculated AVA is sufficient
to diagnose severe AS. However, there is a subset of
patients with depressed LVEF, either due to long-
standing severe AS or due to other causes such as
ischemic cardiomyopathy, in whom the calculated
AVA, MPG, and peak velocity are all low. This
condition was first described in 1980 by Carabello
et al. (5) and has been termed low-flow, low-
gradient AS. A more appropriate term might be
low-gradient severe aortic stenosis (LGSAS), as
mild AS is expected to have a low gradient. More
recently, LGSAS has been shown to also occur in
patients with preserved LVEF and low forward
stroke volume (6). Although much has been learned
about LGSAS since 1980, it remains a complicated
problem for which cardiac imaging plays a crucialrole. This review will cover the use of various
imaging modalities to evaluate hemodynamics, LV
function, and outcomes in patients with LGSAS.
Hemodynamics. By definition, LGSAS includes
both severe AS and a low gradient, which may seem
contradictory. To fully understand the relationship
between AVA, flow, and gradient in LGSAS, it is
helpful to consider the Gorlin hydraulic orifice
equation (7). It is based on the principle that
effective orifice area (EOA) is dependent on flow
and velocity across the valve as shown in Equation
1, where
EOA  Flow/Velocity
Gorlin and Gorlin used cardiac output to derive
systolic flow across the aortic valve and velocity was
estimated from the MPG using Torricelli’s law.
Thus, the Gorlin equation describes the relation-
ship between AVA, flow, and gradient in AS
derived by Equation 2,
AVA  CO  HR  SEP/44.3  MPG
where CO  cardiac output, HR  heart rate, and
SEP  systolic ejection period.
The constant value 44.3 is empirical and includes
both a contraction coefficient and a discharge coef-
ficient. The discharge coefficient accounts for the
energy loss that occurs from conversion of potential
energy (pressure) to kinetic energy (velocity). The
calculated AVA is the EOA of the flow stream,
which is smaller than the anatomic orifice area
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186(AOA). The ratio of EOA to AOA is the contrac-
tion coefficient, which can vary with flow and orifice
geometry. The denominator of the Gorlin equation
equals velocity across the stenotic valve, which is
calculated from MPG. Doppler echocardiography,
which had not been invented at the time of the
Gorlin paper, can be used to directly measure aortic
valve velocity. Had Doppler echocardiography been
available in 1951, it is likely that the denominator of
the Gorlin equation would be velocity rather than
the square root of MPG.
Continuity equation. Equation 1, from which the
Gorlin equation was derived, is also the basis for the
continuity equation, which is the preferred modality
for measuring AVA according to the American
Heart Association (AHA)/American College of
Cardiology (ACC) and European Society
of Cardiology (ESC)/European Associa-
tion of Thoracic Surgery (EATS) guide-
lines (3,4). The continuity equation uses
Doppler velocity-time integral (VTI) and
left ventricular outflow tract (LVOT)
measurements to calculate stroke volume
proximal to the aortic stenosis and the
VTI of the AS jet as shown in Equation 3:
AVA  AreaLVOT  VTILVOT/VTIAS
Peak velocity can be substituted for
VTI, but the latter value is more accurate
and reproducible. The continuity equation
is mathematically equivalent to the Gorlin
equation, but the numerator (flow or flow
rate) is determined by Doppler echocar-
diography instead of Fick or thermodi-
lution, and the denominator (velocity) is
directly measured instead of calculated from the
MPG.
Low-Flow, Low-Gradient Aortic Stenosis
True AS versus pseudo-AS. Accurate assessment of
AVA in patients with LGSAS is difficult because
the Gorlin constant varies at low-flow states and the
calculated AVA is directly proportional to forward
flow (8,9). Cannon et al. (10) reported that some
patients with LGSAS were found to have mild AS
at surgery despite a calculated AVA by the Gorlin
equation suggesting severe AS. Thus, a low calcu-
lated AVA could represent pseudo-AS, in which
the calculated value is artificially low because for-
ward flow is too low to open a mildly or moderately
re
ion
ow
ientdiseased aortic valve, or an error in the calculated nAVA. The first step in evaluating a patient with
LGSAS is to carefully evaluate the possibility of a
measurement error. Thermodilution cardiac output
may be erroneous in low output states or tricuspid
regurgitation (11), leading to a falsely low AVA by
the Gorlin equation. With the continuity equation,
underestimation of the LVOT diameter can signif-
icantly underestimate AVA because any error in its
measurement is squared (12). It is best to make this
measurement at the base of the aortic annulus
rather than the mid-LVOT level. It is important for
the sonographer to position the scan plane in the
center of the LVOT to find the largest diameter. In
addition, the continuity equation assumes circular
geometry, but recent studies using computed to-
mography (CT) demonstrate that both the LVOT
and aortic annulus are often noncircular (13–15).
This may lead to an average 17% underestimation
of LVOT area, and hence, AVA (13). The mea-
surement error at the annulus level may be less than
17%, as the annulus is sometimes more circular than
the LVOT. It is common to encounter very low AVA
in patients with nearly normal aortic valve morphol-
ogy on echocardiography due to underestimation of
the LVOT area. This is particularly problematic in
small elderly women with measured LVOT diam-
eters of 1.6 to 1.8 cm. In such cases, the use of
3-dimensional (3D) echocardiography, CT, or car-
diac magnetic resonance may be helpful in obtain-
ing a more accurate measure of aortic annulus area
(Fig. 1). It can also be helpful to corroborate LV
stroke volume by calculation of LV end-diastolic
and end-systolic volumes, which works well in the
absence of significant mitral regurgitation. This is
often done by biplane method of disks, a technique
that is prone to underestimation by foreshortening.
The most accurate and reproducible methods for
LV volumes are 3D echocardiography (16) or cine
magnetic resonance imaging (17). Most studies of
LGSAS have used the continuity equation, and
despite its potential to underestimate AVA, it
remains the reference standard (4).
Role of dobutamine echocardiography. The ACC/
HA guidelines on management of valvular heart
isease recommend dobutamine echocardiography
DE) to distinguish between true LGSAS and
seudo-AS (Class 2a recommendation) (3). Figure 2
llustrates the rationale for the use of DE in
GSAS, based on Gorlin formula plots of the
elationship of transvalvular flow, MPG, and AVA
18). At low transvalvular flow rates (dashed line at
25 ml/s), MPG is low regardless of AVA. AtA B B R E V I A T I O N S
A N D A C R O N YM S
AOA anatomic orifice area
S aortic stenosis
AVA aortic valve area
DE dobutamine
echocardiography
EOA effective orifice area
LGSAS low-gradient seve
ortic stenosis
VEF left ventricular eject
raction
VOT left ventricular outfl
ract
PGmean pressure grad
AVI transcatheter aortic
alve implantormal transvalvular flow (250 ml/s), MPG is able
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187to clearly separate mild, moderate or severe AS. In
1995, deFilippi et al. (19) first reported the use of
DE to evaluate LGSAS in 18 patients with severe
symptoms and LV dysfunction. All patients had a
calculated AVA 0.5cm2/m2, mean gradient 30
mm Hg and LVEF 45%. Dobutamine was
tarted at 5 g/kg/min and increased to a peak of 20
g/kg/min at 3-min intervals. Three types of re-
sponses were observed: true AS, pseudo-AS, and
absence of contractile reserve. True AS was char-
acterized by dobutamine-induced increase in peak
velocity, MPG and valve resistance with no signif-
icant change in AVA. Pseudo-AS was character-
ized by an increase in AVA by 0.3 cm2 with no
significant change in MPG and peak velocity.
Presence of contractile reserve was defined as in-
crease in peak velocity of 0.6m/s, stroke volume
20% and MPG 10 mm Hg with dobutamine.
Absence of contractile reserve did not help differ-
entiate between true AS or pseudo-AS because
there was no change in forward stroke volume.
Figure 3 shows Doppler spectra from a patient with
Figure 1. Example of Underestimation of LVOT Diameter by 2D
(A) Parasternal long-axis view showing a left ventricular outﬂow tra
cm, resulting in a calculated aortic valve area (AVA) 0.9 cm2, consis
scan in the same patient showing a noncircular LVOT, with the sam
planimetry, calculated AVA is 1.1 cm2. (C) CT scan from a different
minor and major axis diameters of 2.4 cm and 3.0 cm, respectively.
the aortic annulus in the same patient also show elliptical geometr
matching the CT scan. 2D  2-dimensional.true AS, in whom peak velocity increases from 3.2 tto 4.1 m/s after dobutamine. Figure 4 shows con-
tinuous wave and pulsed wave Doppler with dobut-
amine infusion with no significant increase in peak
velocity and MPG but increase in aortic valve area
by continuity equation consistent with pseudo-AS.
The ability of DE to distinguish true LGSAS from
pseudo-AS, and to identify contractile reserve has
been reported by many authors. However, the exact
criteria that optimally distinguish true AS from
pseudo-AS have not been rigorously studied, nor is
there an established reference standard for compar-
ison. The most recent guidelines indicate that true
AS is characterized by 0.2 cm2 increase in AVA,
hile still 1.0 cm2 with an increase in MPG to
40 mm Hg (4). Conversely, pseudo-AS has “a
marked increase in valve area but only minor
changes in gradients” (4). However, outcomes stud-
ies (as will be discussed) indicate that DE is a
valuable diagnostic tool in LGSAS.
Technical aspects of DE. As noted above, accurate
easurement of the LVOT diameter is of para-
ount importance (12–15). CT scans done prior to
ocardiography in a Patient with Aortic Stenosis
VOT) diameter measured at the base of leaﬂet insertion of 2.4
with severe aortic stenosis (AS). (B) Computed tomography (CT)
iameter of 2.4 in the minor axis plane. Using actual LVOT area by
nt at the level of the aortic annulus. The annulus is elliptical with
Three-dimensional transesophageal echocardiography images at
th minor and major axis diameters of 2.4 cm and 2.8 cm, closelyEch
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188show elliptical LVOT and aortic annulus geometry
(14,15). 3D echocardiography may prove to be
useful in measuring the actual LVOT cross-
sectional area to obtain more accurate values of
AVA by the continuity equation (13). Peak aortic
velocity should be measured from multiple views
including apical, right parasternal and suprasternal
views. Continuous wave and pulsed wave Doppler
should be measured at each stage. For each Doppler
measurement 3 to 5 cycles should be averaged and post–
premature ventricular contraction beats should be dis-
carded. The infusion rate of dobutamine does not need
to exceed 20g/kg/min as the inotropic effect is maximal
t this dose and further increases in dose merely add to
he chronotropic response and can provoke ischemia and
rrhythmia in these patients (14). Ischemia is counter-
roductive in evaluating LGSAS, as it may depress
lobal LV systolic function and reduce transvalvular flow
ate rather than augment it. In patients with AS and
evere coronary artery disease, dobutamine may provoke
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Figure 2. Plot of Relationship Between Mean Gradient (Y Axis)
for 3 Different AVA Values (0.7, 1.0, and 1.5 cm2)
Cardiac output (top) assuming a heart rate of 75 beats/min and sys
gradient AS is shown by the small dotted line at a transvalvular ﬂo
AVA values. However, at a normal transvalvular ﬂow rate of 250 ml
mean gradient. The goal of dobutamine echocardiography (DE) is t
AS is truly severe AS or pseudo-AS caused by an artifact of low-ﬂow
rate of 250 ml/s has been shown to accurately separate true AS fro
Abbreviations as in Figure 1.entricular arrhythmias. This can result in hemodynamicompromise and even death. Dobutamine should be
urned off as soon as the hemodynamic classification of
GSAS is established, or once a peak dose of 20
g/kg/min is completed.
Contractile reserve by DE. Before the use of DE
ecame standard of care, studies of LGSAS patients
ndergoing AVR demonstrated improved func-
ional class and LVEF, but at the cost of increased
erioperative mortality (20,21). Subsequently, it
as found that the presence or absence of contrac-
ile reserve by DE strongly predicts operative mor-
ality (22–27) and long-term mortality (Table 1).
onin et al. (24) enrolled 136 patients with AVA
1.0 cm2, cardiac index 3.0 l/min/m2 and MPG
40 mm Hg in a multicenter study. LV contractile
reserve was present in 92 patients and absent in 44
patients. Operative mortality was 5% in patients
with contractile reserve, whereas it was 32% if
contractile reserve was absent (24). Other predictors
of operative mortality and decreased long-term
r Flow (ml/sec)
es HR 75 bpm, SEP 300 ms)
225 250 275 300 325 350 375 400
6.0 8.0
AVA 1.0 AVA 1.5
Transvalvular Flow (X Axis) According to the Gorlin Formula
ejection period (SEP) of 300 ms. The problem of low-ﬂow, low-
ate of 125 ml/s. Mean gradient is less than 20 mm Hg for all three
ild, moderate, and severe AS can be readily distinguished by
crease transvalvular ﬂow rate in order to determine if low-gradient
te. Normalizing AVA and mean gradient to a transvalvular ﬂow
seudo-AS. This ﬁgure is modiﬁed from a ﬁgure in Grayburn (18).ula
um
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189morbidities, very low pressure gradients (20 mm Hg),
presence or absence of atrial fibrillation and severe
associated coronary artery disease (25).
Quere et al. (26) showed that in those patients
who had no contractile reserve on pre-operative
DE, but survived the perioperative period, 90% had
an improvement in their functional class and 65%
showed a post-operative increase in LVEF by at
least 10%. Tribouilloy et al. (27) found that 5-year
survival after AVR compared to medical therapy in
patients with LGSAS and no contractile reserve
was 54% versus 13%, despite a high operative
mortality of 22%. Thus, absence of contractile
reserve should not preclude AVR, even though it
clearly portends a higher operative mortality.
Projected AVA at normal ﬂow. One of the limitations
of DE is the different transvalvular flow rates
achieved in different patients with dobutamine. As
shown already in Figure 2, at low-flow rates, there
Figure 3. Example of DE in a Patient With True LGSAS
(A) Baseline continuous wave (CW) Doppler tracing with peak veloc
CW Doppler during dobutamine infusion at 10 g/kg/min. Peak ve
remained at 0.5 cm2. (C) Speckle tracking in an apical 4-chamber vi
cating severely abnormal myocardial function. LGSAS  low-gradieis little difference in mean gradient between AVA pvalues corresponding to mild, moderate, or severe
AS. Similarly, AVA is flow-dependent, which is
the underlying basis for pseudo-AS. Therefore, it
would be ideal to compare AVA in different patients
at a common, normalized flow rate. Blais et al. (28)
proposed the attractive idea of using DE to calcu-
late projected AVA at normal transvalvular flow
rate of 250 ml/s. This is simply done by plotting
transvalvular flow and AVA at baseline and peak
dobutamine and extrapolating the value for AVA at
a flow rate of 250 ml/s (29). This allows comparison
of AVA (and mean gradient) between patients at a
standardized normal flow rate. Clavel et al. (30)
have shown that projected AVA at normal trans-
valvular flow is an important predictor of outcome
in LGSAS and depressed LVEF.
Other imaging modalities. DE is not able to distin-
uish true AS from pseudo-AS in patients who fail
o increase transvalvular flow in response to inotro-
.2 m/s, mean gradient 25 mm Hg, calculated AVA 0.45 cm2. (B)
y increased to 4.1 m/s, mean gradient to 39 mm Hg, and AVA
(D) Results of global longitudinal strain, which was 5.5%, indi-
vere aortic stenosis; other abbreviations as in Figures 1 and 2.ity 3
locit
ew.ic stimulation (absent contractile reserve). Other
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190imaging modalities can be helpful in such patients.
One simple, and often overlooked, method is sim-
ply evaluating aortic valve morphology on echocar-
diography. True AS would be expected to have
significant calcification and immobility of the aortic
cusps. A morphologically normal or nearly normal
aortic valve would indicate that AVA was calculated
erroneously, or the velocity profile is coming from a
different location than the aortic valve, such as
subvalvular or supravalvular obstruction. Occasion-
Table 1. Perioperative Mortality and Long-Term Survival in Ope
First Author (Ref. #)
Presence of Contractile Res
Perioperative Mortality
Rate for Patients With
AVR With/Without
CABG
Monin et al. (22) 8%
Schwammenthal et al. (23) 0%
Monin et al. (24) 5%
Levy et al. (25) 8%
Quere et al. (26) 6%
Tribouilloy et al. (27) —
Figure 4. Example of DE in a Patient With Pseudo-AS
CW Doppler spectra at baseline, 5 g/kg/min, 10 g/kg/min, and 2
dobutamine, peak velocity remained fairly constant, but AVA increa
and absence of severe AS. Abbreviations as in Figures 1, 2, and 3.CABG  coronary artery bypass graft; DE  dobutamine echocardiography; LGSASally, a continuous wave Doppler profile from mitral
regurgitation can be mistaken for AS. Fluoroscopy
or CT scanning would be expected to show signif-
icant aortic valve calcification in true AS (Fig. 5).
Aortic valve calcium score measured by multislice
CT has been useful in differentiating true AS from
pseudo-AS in patients with depressed LVEF (31).
A calcium score 1,651 had 93% sensitivity and
75% specificity in identifying patients with true AS.
Further validation of aortic valve calcium by CT,
d Patients of LGSAS With and Without Contractile Reserve
by DE Absence of Contractile Reserve by DE
ng-Term
rvival in
perated
atients
Perioperative Mortality
Rate for Patients With
AVR With/Without
CABG
Long-Term
Survival in
Operated
Patients
at 5 years 50% —
— — —
at 3 years 32% —
38%
at 2 years 33% 90% at 2 years
— 22% 54% at 5 years
/kg/min, respectively. At increasing levels of forward ﬂow with
from 1.0 cm2 to 1.4 cm2, demonstrating both contractile reserverate
erve
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92%0 g
sed low-gradient severe aortic stenosis.
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191including outcomes endpoints, is needed. Cine
magnetic resonance imaging is also capable of
calculating AVA by continuity equation using
phase velocity encoding with good correlation to
echocardiography (32–34). Positron emission to-
mography has shown smaller resting myocardial
flow reserve in patients with true stenosis compared
to pseudo-AS (35), although this does not directly
assess aortic valve pathology and is not available in
many centers.
Paradoxical LGSAS with Preserved LVEF
Up to 30% of patients who undergo echocardio-
graphic assessment of AS severity have discrepancy
in echocardiographic parameters such that AVA
indicates severe stenosis but mean gradient is in the
nonsevere range despite a normal LVEF (36). One
potential cause is paradoxical LGSAS with pre-
served LVEF, defined as indexed AVA0.6 cm2/m2)
and LVEF 50% (6). “Paradoxically” low transval-
vular flow rate (defined as a stroke volume index
35 ml/m2) was present in 35% of 512 subjects.
Compared with normal flow patients, low-flow
patients had a higher prevalence of female gender,
lower MPG (40 mm Hg), lower LV diastolic
volume index, lower LVEF (but still50%), higher
level of LV global afterload and lower 3 year
survival (76% vs. 86%). Barasch et al. (37) also
showed that patients with severe AS with AVA
index of 0.46 cm2/m2 and low mean gradient
Figure 5. CT Scan Showing Extensive Aortic Valve Calcium in
a Patient With LGSAS
LC  left coronary cusp; NC  noncoronary cusp; RC  right
coronary cusp; other abbreviations as in Figures 1 and 3.(30 mm Hg) with preserved LV function had a ahigher mortality and a lower rate of referral (50%)
for surgery compared to patients with mean gradi-
ents 30 mm Hg. Clavel et al. (38) have shown
that paradoxical low-flow LGSAS patients have
1.7-fold increase in total mortality and a 2-fold
increase in cardiovascular mortality compared to
patients with severe AS with high gradient. AVR
was associated with improved outcomes (HR: 0.50;
p  0.04) in these patients (38). Recently, Lancel-
otti et al. (39) have shown that prognosis is better
ith normal flow, low-gradient AS than with low-
ow, low-gradient or high-gradient AS. Such pa-
ients are common and most likely represent mod-
rate rather than severe AS. Figure 6 presents a flow
iagram for classification of patients as first pro-
osed by Dumesnil et al. (40). Proper classification
f these patients can be challenging, as clinical
cenario of LGSAS with preserved LVEF may arise
n different situations as described by Zoghbi (41).
hese disparate situations include: 1) mildly re-
uced stroke volume in patients with normal LV
ize; 2) small LV cavity with a small body habitus;
) calculation errors by underestimating LVOT
iameter or malposition of Doppler sample volume;
) presence of systemic hypertension; or 5) incon-
istency in the definition of AS by current guide-
ines because AVA of 1 cm2 does not correspond to
mean gradient 40 mm Hg by the Gorlin
quation (Fig. 2). Jander et al. (42) investigated the
rognostic impact and progression rate of LGSAS in
he SEAS (Simvastatin and Ezetimibe in Aortic
tenosis) trial and showed that the outcome of
atients with LGSAS and normal LVEF was
imilar to patients with moderate AS. Although
hese data seem to conflict with those of the studies
f Hachicha et al. (6) and Barasch et al. (37),
atients in the SEAS study were asymptomatic and
ad less LV hypertrophy for a given level of AVA,
ndicating minimal pressure overload. SEAS pa-
ients were also selected for having nonsevere AS
nd no immediate indication for AVR.
The pathophysiology of LGSAS with preserved
VEF has been explained as being similar to
estrictive physiology. Dumesnil et al. (40) de-
cribed the decrease in stroke volume due to a
eficiency in ventricular filling in relation to a
maller cavity size. In patients with increased after-
oad, sarcomeres are added in parallel causing in-
reased LV thickness such that they have normal
VEF despite myocardial dysfunction and low
troke volume index. In a study of 208 patients,
ombination of decreased systemic arterial compli-
nce (measured as stroke volume index divided by
s 1
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192pulse pressure) and moderate AS was similar with
regard to total LV afterload to patients with severe
AS and normal arterial compliance (43). Myocar-
dial strain, measured by echocardiographic speckle
tracking, was abnormal despite preserved LVEF.
Abnormalities in myocardial strain and strain rate
provide a more sensitive marker for LV dysfunction
than LVEF. Delgado et al. (44) have shown re-
duced longitudinal, circumferential and radial strain
in patients with severe AS and preserved LVEF,
which improved after AVR without change in
LVEF. In a multicenter prospective study of 340
patients with severe AS (AVA index 0.6 cm2/m2)
and preserved LVEF (50%), 9% of patients were
identified as having true low-flow (systolic volume
index: 35 ml/m2) LGSAS (45). They found that
longitudinal strain was particularly abnormal in 2
groups of patients with high afterload-low-flow
high-gradient and low-flow, low-gradient AS. An
Echocardiographic evidence of th
ESC/EATS Class IIa indication for AVR if symptomatic
LGSAS Pseudo-AS
Carefully assess peak velocity, mean pressur
AVA <1.0 cm2 (<0.6 cm2/m2)
Peak velocity >4 m/s, or
MPG >40 mm Hg with
Normal LVEF (≥50%) and
Normal flow (SVI ≥35 ml/m2)
AVA <1.0 cm2 (<0.6 cm2/m2)
Peak velocity <4 m/s, or
MPG <40 mm Hg with
Normal LVEF (≥50%) and
Low flow (SVI <35 ml/m2)
Normal flow,
High gradient AS
Low flow, low gradient AS
with preserved LVEF
ACC/AHA and ESC/EATS
Class I indication for AVR
if symptomatic
ESC/EATS Class IIa indication
for AVR after verifying severe
AS if symptomatic
MPG > 40 mmHg; or peak velocity
increases > 0.6 m/s; AVA <1.0 cm2
AVA increases ≥ 0.3cm2 wi
change in MPG or peak v
Figure 6. Algorithm for Classiﬁcation of Patients With Suspecte
Based on Dumesnil et al. (40), Lancellotti et al. (39), and the recentl
of Thoracic Surgery (EATS) guidelines (4). Abbreviations as in Figureabnormality in longitudinal strain appears to be theearliest marker of LV dysfunction in patients with
increased afterload. Cardiac cine-magnetic reso-
nance imaging with delayed hyperenhancement us-
ing gadolinium contrast agents has shown myocar-
dial fibrosis in at least one segment in patients with
severe LGSAS, either with preserved or depressed
LVEF (46). Late enhancement has been mainly
observed in the subendocardial layers of the basal
segments (46). Mitral ring displacement decreases
gradually with increasing number of hyperenhanc-
ing segments. The longitudinal fibers are mainly
present in the subendocardium and are most sus-
ceptible to the effects of ischemia and increased wall
stress under conditions of increased afterload. It is
reasonable to hypothesize that patients with exten-
sive fibrosis/scarring would be less likely to demon-
strate improved LV function after AVR.
Guidelines for management of LGSAS. The recent
2012 European Society of Cardiology guidelines for
ed leaflets with reduced mobility
Aggressive Medical Therapy
adient (MPG), AVA, LVEF and stroke volume
AVA <1.0 cm2 (<0.6 cm2/m2)
Peak velocity <4 m/s, or
MPG <40 mm Hg with
Normal LVEF (≥50%) and
Normal flow (SVI ≥35 ml/m2)
AVA <1.0 cm2 (<0.6 cm2/m2)
Peak velocity <4 m/s, or
MPG <40 mm Hg with
Depressed LVEF (<50%) and
Low flow (SVI <35 ml/m2)
Normal flow, low gradient AS
with preserved LVEF
Low flow, low gradient AS
vs Pseudo-AS
Consider non-severe AS
or measurement error
Dobutamine Stress
Echocardiography
Contractile Reserve
(SVI increases > 20%)
inor
ity
No Contractile Reserve
(SVI increases < 20%)
ESC/EATS Class IIb
indication for AVR
if symptomatic
or
SAS
dated European Society of Cardiology (ESC)/European Association
and 3.icken
e gr
th m
eloc
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b
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193mention indications for AVR in patients with
LGSAS (4). AVR may be considered a Class IIa
recommendation in the following two circum-
stances: 1) “symptomatic patients with low-flow,
low-gradient (40 mm Hg) AS with normal EF
only after careful confirmation of severe AS”; and
2) “symptomatic patients with severe AS, low flow,
low gradient with reduced EF, and evidence of flow
reserve” (4).
Furthermore, AVR may be considered a Class
IIb recommendation in “symptomatic patients with
severe AS, low flow, low gradient with LV dysfunc-
tion without flow reserve.” In patients with pseudo-
AS, management should be targeted to the under-
lying LV dysfunction (47), and should include
aggressive heart failure therapy and cardiac resyn-
chronization if indicated by LVEF 35% and left
bundle branch block.
Role of TAVI in LGSAS. The development of TAVI as
an alternative to AVR for high-risk patients may be
well suited to this group of patients. Clavel et al.
(48) reported that TAVI was superior to AVR in a
subset of patients with low LVEF at baseline,
although not all of the patients had LGSAS.
Ben-Dor et al. (49) reported the outcomes of high
risk patients with LVEF 40% undergoing either
TAVI or AVR. Late mortality was higher with
LGSAS (54%) than with high gradient (41%) but
LV functional recovery occurred with both TAVI
and AVR in survivors. Lauten et al. (50) published
their results of TAVI in 149 patients (from the German
TAVI registry) with LGSAS (40 mm Hg) with lowet al. Guidelines on the management 115:2856 – 64.for the LGSAS group compared with 18% in
patients with normal LV function. This clearly
demonstrates that TAVI is feasible in this group of
patients, although the mortality rate was high and
typical of that expected for open AVR. The ulti-
mate role of TAVI in LGSAS without contractile
reserve will need to be evaluated in a randomized
controlled trial.
Conclusions
Low-gradient AS presents a challenging clinical
situation. In patients who have depressed LV sys-
tolic function (LVEF 45%), DE helps in differ-
entiating true AS from pseudo-AS and also gives
valuable prognostic information. In general, pa-
tients with true AS can undergo surgery with a low
operative mortality and improved long-term out-
comes. In patients with preserved LVEF (LVEF
50%) it is important to determine the cause of low
forward stroke volume, and to distinguish LGSAS
from an erroneous calculation of AVA. Other
imaging techniques, including speckle tracking to
evaluate LV myocardial performance, cine-magnetic res-
onance imaging to evaluate LV scarring/fibrosis and
CT scanning to assess aortic valve morphology may
help in evaluating LGSAS.
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